Testing Informed Decision Making in Lung Cancer Screening
TIDiL
2 other identifiers
interventional
80
1 country
1
Brief Summary
Lung cancer screening rates are very low despite the fact that lung cancer screening could save many lives. People need to understand the risks and benefits to screening as well as their own beliefs about screening. This study builds an intervention in real world primary care that will help people make the right decision for them as well as help people to quit smoking. Interventions like this are needed to improve the screening rate and reduce death from lung cancer, which is the leading cancer killer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable lung-cancer
Started Jul 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2020
CompletedFirst Submitted
Initial submission to the registry
June 9, 2021
CompletedFirst Posted
Study publicly available on registry
June 25, 2021
CompletedResults Posted
Study results publicly available
October 20, 2022
CompletedSeptember 18, 2023
September 1, 2023
2.2 years
June 9, 2021
July 18, 2022
September 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Patients Who Received a Low Dose CT Scan of the Chest
Percentage of individuals who have evidence of a low-dose CT scan of the chest in their electronic medical record at 1 year post intervention, as ascertained by chart audit by research assistance.
1 year
Study Arms (1)
Phone-delivered decision-counseling program for shared decision making in lung cancer screening
EXPERIMENTALAll individuals who are eligible for lung cancer screening according to USPSTF criteria were invited to participate in the study and all patients who accepted the invitation and consented were slated to receive the intervention which was a phone-delivered on line decision-counseling program (DCP) and there was no one randomized or enrolled into a control group, nor was anyone randomized or enrolled into a usual care group.
Interventions
Telephone delivered non-persuasive shared decision-making for lung cancer screening.
Eligibility Criteria
You may qualify if:
- Current or former smoker
- Greater than or equal to 30 pack years smoking
You may not qualify if:
- Prior CT in last year
- Quit smoking greater than 15 years ago
- Current diagnosis of lung cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Christiana Care Health Serviceslead
- Thomas Jefferson Universitycollaborator
- University of Delawarecollaborator
- National Institute of General Medical Sciences (NIGMS)collaborator
Study Sites (1)
Christiana Care Health System
Newark, Delaware, 19718, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Heather Bittner Fagan, MD MPH
- Organization
- Christiana Care Health System
Study Officials
- PRINCIPAL INVESTIGATOR
Heather B Fagan, MD
Christiana Care Health Services
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician - Family Medicine
Study Record Dates
First Submitted
June 9, 2021
First Posted
June 25, 2021
Study Start
July 18, 2018
Primary Completion
September 30, 2020
Study Completion
October 30, 2020
Last Updated
September 18, 2023
Results First Posted
October 20, 2022
Record last verified: 2023-09